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Abstract
Background: Preclinical studies support the assumption that connective tissue grafts preserve the alveolar bone
from resorption; the underlying cellular mechanisms, however, remain unknown. The cellular mechanisms may be
attributed to the paracrine activity of the palatal fibroblasts. It was thus reasonable to suggest that palatal
connective tissue grafts reduce the formation of osteoclasts.
Methods: To test this hypothesis, human palatal fibroblasts were examined for their capacity to modulate the
formation of osteoclasts in murine bone marrow cultures exposed to RANKL, M-CSF and TGF-β1. Osteoclastogenesis
was determined by tartrate-resistant acid phosphatase (TRAP) staining and gene expression analysis. The formation
of antigen presenting cells was based on the expression of CD14 and costimmulatory molecules of antigen
presenting cells. The paracrine interaction of fibroblasts and the bone marrow was modeled in vitro with inserts of
cell-occlusive membranes.
Results: In cocultures without cell-to-cell contact, palatal fibroblasts caused a decrease in the expression of the
osteoclast marker genes in bone marrow cells; calcitonin receptors, cathepsin K, TRAP, and osteoclast-associated
receptor. Also the number of TRAP positive multinucleated cells was decreased in the presence of fibroblasts.
Notably, palatal fibroblasts increased the expression of CD14 and the co-stimulatory proteins CD40, CD80, and CD86
in bone marrow cells. Bone marrow cells had no considerable impact on fibroblast viability and proliferation marker
genes. With regard to cell distribution, osteoclasts were most prominent in the center of the membranes, while
fibroblasts accumulated immediately adjacent to the border of the insert forming a ring-like structure on the
surface of the culture plate.
Conclusion: The data suggest that palatal fibroblasts provide a paracrine environment that reduces
osteoclastogenesis and increases markers of antigen presenting cells. Morover, the paracrine model revealed a joint
activity between palatal fibroblasts and bone marrow cells visualized by the characteristic cell distribution in the
two separated compartments.
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Background
Palatal connective tissue grafts are used in periodontol-
ogy for root coverage and to treat gingival recession de-
fects [1]. Palatal connective tissue grafts have also been
proposed to improve esthetic parameters when buccal
bone is thin or resorbed in implant dentistry and pros-
thetics [2–6]. Depending on the technique used, palatal
connective tissue grafts can be placed in direct contact
with alveolar bone. The question arises about the pos-
sible impact of the palatal connective tissue grafts on the
alveolar bone. There is at least weak support for a po-
tential role of connective tissue grafts in preserving the
underlying bone. Connective tissue graft placed at the
buccal aspect of the bony wall, immediately after tooth
extraction, yielded a reasonable preservation of the hard
tissues [7]. Moreover, gingival connective tissue grafts
can reduce the resorption of the marginal crest in canine
models [8]. Taken together, both preclinical studies sup-
port the assumption that connective tissue grafts can
preserve the alveolar bone; the underlying cellular mech-
anism however remains unknown.
The cellular mechanism may be attributed to the para-
crine activity of the palatal fibroblasts. This assumption
is supported by in vitro experiments with isolated gin-
giva fibroblasts and their ability to influence osteoclasto-
genesis, the formation of bone-resorbing cells. For
example, conditioned medium obtained from gingiva fi-
broblasts and periodontal ligament fibroblasts inhibit the
formation of osteoclast-like cells in mouse bone marrow
cultures [9–11]. It is thus likely that paracrine factors re-
leased from palatal fibroblasts can reduce the process of
osteoclastogenesis. More intriguing is to understand the
molecular mechanism how the paracrine factors released
from palatal fibroblasts change the expression of genes
representing osteoclasts, but also the antigen presenting
cells, both originating fom hematopoetic precursor cells.
Osteoclastogenesis in murine bone marrow cultures
requires the presences of receptor activator of nuclear
factor kappa-B ligand (RANKL), M-CSF, and the respect-
ive receptors [12]. Osteoclasts typically are multinucleated
and express tartrate-resistant acid phosphatase (TRAP),
cathepsin k (CatK) and the calcitonin receptor (CTR). Os-
teoclasts also express co-stimulatory molecules activating
the immunoreceptor tyrosine-based activation motif
(ITAM)-dependent pathway [13]. Osteoclast-associated
receptor (OSCAR) and triggering receptor expressed in
myeloid cells (TREM2) are receptors that are associated
with the respective adaptor molecules Fc receptor
common gamma chain (FcRγ) and DNAX-activating
protein 12 kDa (DAP12), respectively [13]. When the
differentiation shifts towards a macrophage pheno-
type, the expression of CD14, a co-receptor for lipo-
polysaccharide signaling, and the co-stimulatory
proteins CD40, CD80 and CD86, commonly expressed
in antigen presenting cells such as monocytes and
macrophages, rise [14, 15].
Aim of this present pilot study was to investigate the
impact of the paracrine environment of palatal fibro-
blasts on osteoclastogenesis from bone marrow precur-
sors using a in vitro model where both cell sources are
separated by cell occlusive membranes.
Methods
Human palatal fibroblast
Human palatal fibroblasts were prepared from explant
cultures of three independent donors after approval of
the ethical committee of the Medical University of
Vienna (EK Nr. 631/2007). Fibroblasts that grew out
from the explants and had not undergone more than five
passages were used. Fibroblasts were cultivated in
Dubeccos Modified Eagle Medium (DMEM) with antibi-
otics (Invitrogen Corporation, Carlsbad, CA, USA)) and
plated at 100,000 cells/cm2 in the respective 12-well
plates (Greiner-Bio-One GmbH). After the cultivation
period, staining of the fibroblast was performed with
DiffQuik (Roche Diagnostic Systems, Basel, Switzerland).
Murine bone marrow cultures
Bone marrow cells were prepared by flushing femur and
tibiae of 4 to 8 weeks old female Balb/c mice (BE76/12
Veterinärdienst des Kantons Bern) and seeded into
ThinCert™ cell culture inserts (12 well format with nom-
inal pore sizes of 0.4, μm; Greiner-Bio-One GmbH,
Frickenhausen, Germany) at one million cells per cm2 in
Eagle’s Minimum Essential Medium-Alpha Modification
(αMEM) supplemented with 10 % fetal calf serum (FCS),
antibiotics, M-CSF at 25 μg/ml, TGF-β1 at 10 μg/ml,
and RANKL at 25 μg/ml. Bone marrow cultures were
then transferred to the plates that contained the fibro-
blasts. Recombinant proteins were purchased from Pro-
spec (Ness-Ziona, Israel). Bone marrow cells were
cultivated with and without the fibroblast. Both cell
types remain separated by the cell occlusive membrane
of the ThinCert™ cell culture inserts. Staining for TRAP
(Sigma Aldrich, St. Louis, MO) was performed at day
five. Cells were considered osteoclasts when positive for
TRAP and having three or more nuclei as observed by
light microscopy.
Expression of marker genes in murine bone marrow
cultures
RNA was isolated from the bone marrow cultures and the
palatal fibroblasts using the High Pure RNA Isolation Kit
(Roche Applied Science, Rotkreuz, Switzerland). Reverse
transcription (RT) was performed with Transcriptor
Universal cDNA Master, and PCR analyses were done in
triplicates using TaqMan Universal PCR Master Mix
(Applied Biosystems, Carlsbad, CA) or the FastStart
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Universal Probe Master Rox on a 7500 Real-Time PCR
System (Roche). Bone marrow cells were analyzed for the
following genes: SybrGreen: RANK, C-FMS, TRAF6, C-
FOS, MITF, PU1, NFATC-1, DC-STAMP, ATP6V0D2,
CD14, CD40, CD80, CD86, CD11C; TaqMan (Applied
Biosystems, Carlsbad, CA): CTR, CATK, TRAP,
OSCAR, TREM2, DAP12, FCRγ. Fibroblasts were ana-
lyzed for the following genes: BCL2, PLK1, CCNB1,
CCNE1, CCND1, MYBL2, GAPDH, BAD, BAX, and
BCL-XL. Data were normalized for β-actin using the
ΔΔCt method (Tables 1 and 2).
Statistical analysis
Cell cultures were done using at least tree different
fibroblast donors. The two groups were compared with
the paired-T test with α < 5 %.
Results
Palatal fibroblasts inhibit the osteoclast-like cells pathway
To determine the impact of palatal fibroblast on osteo-
clastogenesis, a paracrine co-culture model based on in-
serts was performed. A main finding was that the
presence of palatal fibroblasts in the lower chamber de-
creased the expression of the typical osteoclast marker
genes CTR, CATK, TRAP and OSCAR by around 30 %
(p < 0.05), but not the other co-stimulatory molecules of
osteoclastogenesis. RANK and c-fms also remained un-
changed. Moreover, TRAP staining was visibly reduced
in the presence of palatal fibroblast. Mean number of os-
teoclasts in co-culture with fibroblasts per region of
interest, randomly selected in each well: 11.7 (SD 6.7).
Mean number of osteoclasts without fibroblasts per re-
gion of interest was 53.0 (SD 12.8; p < 0.05). Importantly,
the presence of palatal fibroblasts increased the expres-
sion of CD14 and the co-stimulatory proteins CD40,
CD80 and CD86 by around 2-4-fold (p < 0.05) compared
to the respective controls without the presence of palatal
fibroblasts (Table 3). Thus, the data support the concept
that the palatal fibroblasts favor the development of anti-
gen presenting cells rather than an osteoclast phenotype.
Bone marrow cells did not affect the viability or the pro-
liferation of the palatal fibroblasts, as indicated by the
expression analysis of apoptosis and cell cycle related
genes (data not shown).
Characteristic distribution of osteoclasts and palatal
fibroblasts in the insert cultures
Palatal fibroblast had a major impact on the distribu-
tion of the osteoclasts. TRAP positive osteoclasts were
prominent in the center of the insert (Fig. 1). Another
phenomenon occurred towards the distribution of the
palatal fibroblasts. The fibroblasts accumulated imme-
diately adjacent to the border of the insert, forming a
ring of high cell density (Fig. 1). These observations ba-
sically support that palatal fibroblasts reduce the forma-
tion of osteoclasts in a paracrine mode of action, but
also that the bone marrow cells can attract fibroblasts
in vitro. Thus, the paracrine model based on cell occlu-
sive membranes with bone marrow cells in the inserts
and fibroblasts in the lower compartment of the culture
Table 1 SybrGreen Primers for RT-PCR
Gene Forward primer Reverse primer
m 18 s tccagcacattttgcgagta cagtgatggcgaaggctatt
m βactin ctaaggccaaccgtgaaaag accagaggcatacagggaca
m RANK gtgctgctcgttccactg agatgctcataatgcctctcct
m c-fms gaccatggtgaatggtaggg ggataacgttgaatcccactg
m TRAF6 ttgcacattcagtgtttttgg tgcaagtgtcgtgccaag
m c-fos gcaactttctatgacactgaaacac tctctctagggctgcattgg
m MITF gacaccagccataaacgtca ttttccaggtgggtctgc
m PU1 ggagaagctgatggcttgg caggcgaatctttttcttgc
m NFATc-1 ccgttgcttccagaaaataaca tgtgggatgtgaactcggaa
m DC-Stamp aagctccttgagaaacgatca caggactggaaaccagaaatg
m Atp6vOd2 aagcctttgtttgacgctgt gccagcacattcatctgtacc
m CD14 aaagaaactgaagcctttctcg agcaacaagccaagcacac
m CD40 gagtcagactaatgtcatctgtggtt accccgaaaatggtgatg
m CD80 tcgtctttcacaagtgtcttcag ttgccagtagattcggtcttc
m CD86 gaagccgaatcagcctagc cagcgttactatcccgctct
m CD11c gagccagaacttcccaactg tcaggaacacgatgtcttgg
h βactin ccaaccgcgagaagatga ccagaggcgtacagggatag
h BCL2 caggagaatggataaggcaaa ccagccagatttaggttcaaa
h PLK1 aaccgagttattcatcgagacc ttggttgccagtccaaaatc
h CCNB1 cctccggtgttctgcttc ttcagcattaattttcgagttcc
h CCNE1 ggccaaaatcgacaggac gggtctgcacagactgcat
h CCND1 gccgagaagctgtgcatc ccacttgagcttgttcacca
h MYBL2 gtcaaatggacccatgagga gtcagtgcggttagggaagt
h GAPDH agccacatcgctcagacac gcccaatacgaccaaatc
h BAD cgagtttgtggactcctttaaga caccaggactggaagactcg
h BAX agcaaactggtgctcaagg tcttggatccagcccaac
h BCL XL agccttggatccaggagaa agcggttgaagcgttcct
Table 2 TaqMan Primers Assay ID for RT-PCR
m CTR Mm 00432282_m1
m CatK Mm 00484039_m1
m TRAP Mm 00475698_m1
m Oscar Mm 00558665_m1
m Trem2 Mm 04209424_g1
m Dap12 Mm 00449152_m1
m FcRγ Mm 02343757_m1
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plate revealed a mutual activity visualized by the differ-
ential cell distribution.
Discussion
The main finding of the present study was that palatal fi-
broblasts created a paracrine environment that moder-
ately suppressed osteoclastogenesis while shifting the
differentiation towards a macrophage phenotype. Osteo-
clast master genes were downregulated in the presence
of fibroblasts, while genes characteristic for antigen pre-
senting cells were upregulated. RANK and c-fms
remained unchanged suggesting that the differentiation
shift can not be explained by a decrease in responsive-
ness to the respective ligands, with M-CSF being critical
also for monocyte development. Moreover, we observed
a characteristic in vitro cell distribution, with osteoclasts
remaining in the centers of the inserts, while the fibro-
blasts accumulated in a ring-like structure.
These in vitro findings are interesting because they ba-
sically support the observations from preclinical studies
that connective tissue grafts reduce the resorption of the
buccal bony wall [7, 8]. It is not surprising that reduced
osteoclastogenesis goes along with a shift toward antigen
presenting cells. Similar observations were made with
saliva [15], and also doxycycline and minocycline in-
duced the expression of dendritic cell markers, CD11c
and CD86, in bone marrow cells in the presence of
RANKL [14]. Taken together, the data provide insights
into a possible paracrine mechanism on how palatal
fibroblasts can reduce osteoclastogenesis while simultan-
eously supporting innate immunity indicated by expres-
sion of markers of antigen presenting cells, at least in
vitro. Clearly this is not a conclusion, rather a suggestion
supported be our preliminary data. Thus, the in vitro
data and particularily the possible clinical relevance need
to be interpreted carefully.
The pilot study has further limitations. This is an ob-
servational study showing a phenomenon, while the
underlying molecular mechanisms remain unclear. The
factors released by the palatal fibroblasts that are re-
sponsible for the observed shift from osteoclastogenesis
towards the formation of as yet not further defined
Table 3 RT-PCR of osteoclast-like cells (OCL) in co-culture with palate fibroblasts (PF) using M-CSF, RANKL and TGF- β1 compared to
co-cultures without PF, with mean values and standard deviation
Target genes CD14 CD40 CD80 CD86 CTR CatK TRAP OSCAR
Mean 3.13 2.48 1.57 4.31 0.63 0.71 0.75 0.62
Standard Deviation 0.66 0.82 0.53 1.42 0.31 0.34 0.31 0.30
The genes were cluster of differentiation 14, 40, 80 and 86 (CD), calcitonin receptor (CTR), cathepsin K (CatK), tartrate-Resistant Acid Phosphatase 5 (TRAP),
osteoclast-associated immunoglobulin-like receptor (OSCAR). The table represents the mean and standard deviation of n = 6 resulting from two independent
experiments with fibroblasts from three different donors. All mean values were different compared to controls without fibroblasts (p < 0.05)
Fig. 1 Staining of fibroblasts in wells and osteoclast-like cells in inserts after incubating murine bone marrow cells for 5 days with M-CSF, RANKL
and TGF-β1 (MRT). Combined cultures with fibroblasts and osteoclasts (a1) showed an accumulation of the fibroblasts immediately adjacent to
the border of the insert, forming a ring of fibroblasts at a high cell density (a2, a3). Moreover, palatal fibroblast had a major impact on the
distribution of the osteoclasts: osteoclasts were prominent in the center of the insert (a4, a5). In cultures were no fibroblasts were present
(b1, b2, b3), the TRAP-staining of the osteoclast-like cells showed a reduction in number and were more uniformly distributed compared to
osteoclast-cells that had interaction with fibroblasts (b4, b5)
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antigen presenting cells remains to be determined. One
likely candidate is osteoprotegerin, a decoy-receptor for
RANKL [12]. Osteoprotegerin is produced by fibroblasts,
but to which extend and, if at all, this factor has caused
the inhibition of osteoclastogenesis is yet unclear. More-
over, we used a xenogeneic system, which might have af-
fected the overall outcome; human palatal fibroblasts
and mouse bone marrow cells. However, molecules play-
ing a role in osteoclast differentiation are evolutionary
conserved and thus work inter-species [16]. Therefore,
the use of mouse bone marrow cells in combination with
human fibroblasts is appropriate as a proof-of-principles
experiment that can be refined by the future use of in-
terspecies in vitro models.
Conclusions
Taken together, the present pilot study is a scientific
basis for future research aiming to reveal the impact of
the paracrine environment of palatal fibroblasts on oste-
oclastogenesis and the respective impact on the innate
immune system. The present study is also a primer to
further study the dynamics of cell movement created by
the mutual paracrine environment.
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